US10385346B2ActiveUtilityA1

Xylosidase having improved enzymatic activity

57
Assignee: DONGGUAN APAC BIOTECHNOLOGY CO LTDPriority: Oct 25, 2017Filed: Oct 11, 2018Granted: Aug 20, 2019
Est. expiryOct 25, 2037(~11.3 yrs left)· nominal 20-yr term from priority
C12N 15/52C12Y 302/01037C12N 15/102C12Y 302/01177C12N 9/2402C12Y 302/01072
57
PatentIndex Score
0
Cited by
5
References
3
Claims

Abstract

A xylosidase having improved enzymatic activity is disclosed. The amino acid sequence of the xylosidase is a modified amino acid sequence of SEQ ID NO: 2, wherein the modification is a substitution of phenylalanine at position 35 with glutamate, and/or a substitution of glutamine at position 41 with histidine.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A xylosidase consisting of a modified amino acid sequence of SEQ ID NO: 2, wherein the modification is a substitution of phenylalanine at position 35 with glutamate, and a substitution of glutamine at position 41 with histidine. 
     
     
       2. A xylosidase consisting of a modified amino acid sequence of SEQ ID NO: 2, wherein the modification is a substitution of phenylalanine at position 35 with glutamate. 
     
     
       3. A xylosidase consisting of a modified amino acid sequence of SEQ ID NO: 2, wherein the modification is a substitution of glutamine at position 41 with histidine.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.